Four biomarkers, including estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki67, are commonly utilized to immunostain the slides to determine molecular subtypes of breast cancer. Here, ESR1 is linked to breast carcinoma.